FORM 8-K


                       SECURITIES AND EXCHANGE COMMISSION


                             Washington, D.C. 20549



                                 CURRENT REPORT


                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934


       Date of Report (Date of earliest event reported): January 27, 2003



                             MEDTOX SCIENTIFIC, INC.
             (Exact name of registrant as specified in its charter)


                                    Delaware
                 (State or other jurisdiction of incorporation)


 1-11394                                                            95-3863205
(Commission File Number)                       (IRS Employer Identification No.)


402 West County Road D
St. Paul, Minnesota                                                      55112
(Address of principal executive offices)                              (Zip Code)


                                 (651) 636-7466
              (Registrant's telephone number, including area code)









Item 9.           Regulation FD Disclosure

     On January  27,  2003,  the company  issued a press  release  regarding  an
industry article that was written  highlighting the company. A copy of the press
release is attached as Exhibit 99.1.






                                   SIGNATURES


Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                               MEDTOX Scientific, Inc.




Date:  January 27, 2003                        By:       /s/ Richard J. Braun
                                                         -----------------------
                                               Name:     Richard J. Braun
                                               Title:    Chief Executive Officer